Carbapenems (Theravance)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCarbapenems (Theravance)
Drug Alias NameGram-negative bacterial infection therapy (Theravance)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoviva Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoviva Inc
Active IndicationsN/A
Inactive IndicationsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A